FDA Clears Rayner's Sophi Phaco System - Takeaway - MDSpire
From the Journals
FDA & Government News

FDA Clears Rayner's Sophi Phaco System

The company said that surgeons and clinical teams can benefit from faster setup, quicker patient turnover, and greater mobility.

Share

  • 1

    Rayner has received FDA clearance for the Sophi system.

  • 2

    Sophi is designed for ASCs, office-based surgery, and hospitals.

  • 3

    It features triple pump fluidics for efficiency.

  • 4

    Faster setup and patient turnover are emphasized.

  • 5

    Potential to reduce surgical waste by 307kg per 1,000 surgeries.

  • 6

    Committed to sustainability in surgery.

  • 7

    Tim Clover highlights the need for alternatives in phaco technology.

  • 8

    Sophi aims to enhance operational efficiency for clinics globally.

Original Source(s)

FDA Clears Rayner's Sophi Phaco System

  • by Conexiant News Staff

  • January 14, 2026

Related Content

Haag-Streit Announces Global launch of METIS 3D Digital Heads-Up Module

Follows module's successful US debut at AAO 2025

  • April 3, 2026

  • 2 min
SEE Program Strengthens Adherence

Personalized glaucoma coaching program boosts medication adherence in randomized trial

  • April 3, 2026

  • 3 min
The Power of Adjustability

Sitting Down With… Ron Kurtz, President and Chief Executive Officer, RxSight